Purple Biotech (PPBT) Receivables (2019 - 2020)
Purple Biotech (PPBT) has disclosed Receivables for 2 consecutive years, with $500000.0 as the latest value for Q4 2020.
- On a quarterly basis, Receivables fell 66.51% to $500000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $500000.0, a 66.51% decrease, with the full-year FY2020 number at $500000.0, down 66.51% from a year prior.
- Receivables was $500000.0 for Q4 2020 at Purple Biotech, down from $1.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $1.5 million in Q4 2019 to a low of $500000.0 in Q4 2020.